Concord Biotech is setting up a tablets unit at Dholka in Ahmedabad district of Gujarat.
A spokesperson for the company disclosed to ProjectsToday (PT) that the company was setting up a unit with a capacity of 24.6 crore nos. per annum in Gujarat. It has already acquired 35 acre for the project.
The project, entailing an investment of Rs 30 crore, is expected to be completed in February 2015. At present, the company is scouting for machinery suppliers for the project.
Related Link:
Project profile